|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 003 |
AR-LpUBP |
| 005 |
20231114191302.0 |
| 007 |
ta |
| 008 |
230904s2004 sp g 000 0 spa d |
| 020 |
|
|
|a 8481747459
|
| 040 |
|
|
|a AR-LpUBP
|b spa
|c AR-LpUBP
|
| 245 |
1 |
0 |
|a Farmacología
|
| 250 |
|
|
|a 5a. ed.
|
| 260 |
|
|
|a Madrid :
|b Elsevier ;
|b Churchill Livingstone,
|c 2004.
|
| 300 |
|
|
|a xii, 797 p. :
|b il ;
|c 28 centímetro
|
| 500 |
|
|
|a Bibliografía y lecturas recomendadas al final de capítulos
|
| 650 |
|
4 |
|a FARMACOLOGIA
|9 9549
|
| 700 |
1 |
|
|a Rang, H. P.
|9 69003
|
| 700 |
1 |
|
|a Dale, M. Maureen
|9 69004
|
| 700 |
1 |
|
|a Ritter, J. M.
|9 69005
|
| 700 |
1 |
|
|a Moore, P. K.
|9 113845
|
| 700 |
1 |
|
|a Lamb, Peter
|e il.
|9 113846
|
| 700 |
1 |
|
|a Iglesias Dorado, Victoria
|e rev.
|9 113847
|
| 942 |
|
|
|a BK
|
| 952 |
|
|
|0 0
|1 0
|2 udc
|4 0
|6 BC_QV_4_FAR_5_EJ_1
|7 0
|8 NFIC
|9 257590
|a DUN
|b DUN
|c BC
|d 2023-10-31
|i 534735
|l 4
|m 2
|o BC QV 4 FAR 5 ej. 1
|p DUN534735
|r 2024-10-24 15:03:44
|s 2024-10-09
|w 2023-10-31
|y BK
|
| 999 |
|
|
|c 179410
|d 179410
|
| 988 |
|
|
|b CLI CLI
|d CLI CLI
|
